These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32819210)

  • 41. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potential Impact of Interventions to Enhance Retention in Care During Real-World HIV Pre-Exposure Prophylaxis Implementation.
    Chan PA; Goedel WC; Nunn AS; Sowemimo-Coker G; Galárraga O; Prosperi M; Patel R; Mena L; Montgomery MC; Marshall BDL
    AIDS Patient Care STDS; 2019 Oct; 33(10):434-439. PubMed ID: 31584857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.
    Reidy M; Gardiner E; Pretorius C; Glaubius R; Torjesen K; Kripke K
    PLoS One; 2019; 14(6):e0218710. PubMed ID: 31242240
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers.
    Mukandavire Z; Mitchell KM; Vickerman P
    Epidemics; 2016 Mar; 14():62-70. PubMed ID: 26972515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment.
    Lancaster KE; Lungu T; Bula A; Shea JM; Shoben A; Hosseinipour MC; Kohler RE; Hoffman IF; Go VF; Golin CE; Wheeler SB; Miller WC
    AIDS Behav; 2020 May; 24(5):1294-1303. PubMed ID: 31720955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acceptability and willingness of HIV pre-exposure prophylaxis amongst female sex workers in China.
    Poon AN; Han L; Li Z; Zhou C; Li Y; Huang L; Liao M; Shepard C; Bulterys M
    AIDS Care; 2019 Dec; 31(12):1555-1564. PubMed ID: 31046413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV pre-exposure prophylaxis for female sex workers: ensuring women's family planning needs are not left behind.
    Bowring AL; Ampt FH; Schwartz S; Stoové MA; Luchters S; Baral S; Hellard M
    J Int AIDS Soc; 2020 Feb; 23(2):e25442. PubMed ID: 32064765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time to Scale Up Preexposure Prophylaxis Beyond the Highest-Risk Populations? Modeling Insights From High-Risk Women in Sub-Saharan Africa.
    Grant H; Gomez GB; Kripke K; Barnabas RV; Watts C; Medley GF; Mukandavire Z
    Sex Transm Dis; 2020 Nov; 47(11):767-777. PubMed ID: 33044426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Audit of patient retention in pre-exposure prophylaxis (PrEP) services in an integrated sexual reproductive health service setting.
    Cochrane E; Knapper C
    Int J STD AIDS; 2019 Dec; 30(14):1432-1435. PubMed ID: 31795927
    [No Abstract]   [Full Text] [Related]  

  • 52. Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-exposure Prophylaxis (PrEP) to Prevent HIV Infection.
    van Epps P; Maier M; Lund B; Howren MB; Beck B; Beste L; Skolnik A; Vaughan-Sarrazin M; Ohl ME
    J Acquir Immune Defic Syndr; 2018 Mar; 77(3):272-278. PubMed ID: 29210835
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
    Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
    BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam.
    Hoornenborg E; Achterbergh RC; van der Loeff MFS; Davidovich U; van der Helm JJ; Hogewoning A; van Duijnhoven YT; Sonder GJ; de Vries HJ; Prins M;
    J Int AIDS Soc; 2018 Mar; 21(3):e25105. PubMed ID: 29603900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa.
    Eakle R; Bourne A; Mbogua J; Mutanha N; Rees H
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29457868
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.
    Marcus JL; Hurley LB; Hare CB; Nguyen DP; Phengrasamy T; Silverberg MJ; Stoltey JE; Volk JE
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):540-546. PubMed ID: 27851714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cohort profile: l'Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada.
    Greenwald ZR; Maheu-Giroux M; Szabo J; Robin JAB; Boissonnault M; Nguyen VK; Thomas R
    BMJ Open; 2019 Jun; 9(6):e028768. PubMed ID: 31248931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial.
    Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE;
    BMC Public Health; 2018 Feb; 18(1):210. PubMed ID: 29394918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city.
    Footer KHA; Lim S; Rael CT; Greene GJ; Carballa-Diéguez A; Giguere R; Martinez M; Bockting W; D'Aquila R; Sherman SG
    AIDS Care; 2019 Oct; 31(10):1207-1213. PubMed ID: 30822101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.